ABC of Smoking Cessation. Bupropion and Other Drugs in Non-nicotine Therapy
Abeceda odvykání kouřeníBupropion a další nenikotinové farmakoterapie
Bupropion je nejúčinnější a bezpečnou nenikotinovou léčbou závislosti na tabáku. Zdvojnásobuje úspěšnost podobnějako náhradní terapie nikotinem. U silně závislých kuřáků je doporučena kombinace těchto léků. Z dalších antidepresivje účinný nortiptylin, dále pak clonidin a mecamylamin. Jejich efekt je však omezený.
Klíčová slova:
odvykání kouření, nenikotinové farmakoterapie.
Authors:
Roddy E. Překlad Králíková E. *; V. Himmerová
Published in the journal:
Čas. Lék. čes. 2004; : 863-865
Category:
Summary
Administration of bupropion is the most effective and safe non-nicotine therapy of tobacco dependence. It doublesthe success rate, similarly as nicotine replacement therapy. In heavy dependent smokers combination of bothmentioned therapies is recommended. From other antidepressant drugs, nortripyline is effective, and then clonidineand mecamylamine. But their effect is restricted.
Key words:
Smoking cessation, non-nicotine pharmacotherapy.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Sexual Asphyxias in Medical Praxis
- Alcohol-related Amnesia („Blackout“) in Broader Perspective
- Thirty Years of the Balloon Catheter – Andreas Gruentzig and Percutaneous Balloon Angioplasty
- Apolipoprotein AV and Triglyceridemia